Literature DB >> 27581055

Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial.

Yoriko Heianza1, Wenjie Ma2, Tao Huang3, Tiange Wang1, Yan Zheng4, Steven R Smith5, George A Bray6, Frank M Sacks4, Lu Qi7,2,4,8.   

Abstract

OBJECTIVE: Fibroblast growth factor 21 (FGF21) is involved in the regulation of energy balance and adipose metabolism. Our previous genome-wide association study identified genetic variants in the FGF21 region associated with macronutrient intake preference. We investigated whether the FGF21 genotype modified effects of weight-loss diets varying in macronutrient intake on changes in adiposity in a 2-year randomized diet intervention trial. RESEARCH DESIGN AND METHODS: We genotyped FGF21 rs838147 in 715 overweight or obese individuals who were assigned to one of four diets varying in macronutrient contents. A DEXA scan was performed to evaluate body composition.
RESULTS: We observed a significant interaction between the FGF21 genotype and carbohydrate/fat intake on 2-year changes in waist circumference (WC), percentage of total fat mass, and percentage of trunk fat (P = 0.049, P = 0.001, and P = 0.003 for interaction, respectively). In response to the low-carbohydrate/high-fat diet, carrying the carbohydrate intake-decreasing C allele of rs838147 was marginally associated with less reduction in WC (P = 0.08) and significantly associated with less reduction of total fat mass (P = 0.01) and trunk fat (P = 0.02). Opposite genetic associations with these outcomes were observed among the high-carbohydrate/low-fat diet group; carrying the C allele was associated with a greater reduction of WC, total body fat mass, and trunk fat.
CONCLUSIONS: Our data suggest that FGF21 genotypes may interact with dietary carbohydrate/fat intake on changes in central adiposity and body fat composition. A low-calorie, high-carbohydrate/low-fat diet was beneficial for overweight or obese individuals carrying the carbohydrate intake-decreasing allele of the FGF21 variant to improve body composition and abdominal obesity.
© 2016 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27581055      PMCID: PMC5079612          DOI: 10.2337/dc16-1111

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


  39 in total

1.  Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.

Authors:  Thomas Reinehr; Joachim Woelfle; Rainer Wunsch; Christian L Roth
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

2.  Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction.

Authors:  Knut Mai; Franziska Schwarz; Thomas Bobbert; Janin Andres; Anke Assmann; Andreas F H Pfeiffer; Joachim Spranger
Journal:  Metabolism       Date:  2010-04-01       Impact factor: 8.694

3.  Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage.

Authors:  Cosimo Giannini; Ariel E Feldstein; Nicola Santoro; Grace Kim; Romy Kursawe; Bridget Pierpont; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-26       Impact factor: 5.958

4.  Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.

Authors:  Daniel Cuevas-Ramos; Paloma Almeda-Valdes; Francisco J Gómez-Pérez; Clara Elena Meza-Arana; Ivette Cruz-Bautista; Olimpia Arellano-Campos; Mariana Navarrete-López; Carlos A Aguilar-Salinas
Journal:  Eur J Endocrinol       Date:  2010-06-21       Impact factor: 6.664

Review 5.  Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.

Authors:  Fangfang Zhang; Lechu Yu; Xiufei Lin; Peng Cheng; Luqing He; Xiaokun Li; Xuemian Lu; Yi Tan; Hong Yang; Lu Cai; Chi Zhang
Journal:  Mol Endocrinol       Date:  2015-08-26

6.  FGF21 and the late adaptive response to starvation in humans.

Authors:  Pouneh K Fazeli; Mingyue Lun; Soo M Kim; Miriam A Bredella; Spenser Wright; Yang Zhang; Hang Lee; Ciprian Catana; Anne Klibanski; Parth Patwari; Matthew L Steinhauser
Journal:  J Clin Invest       Date:  2015-11-03       Impact factor: 14.808

7.  Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.

Authors:  Xinmei Zhang; Dennis C Y Yeung; Michal Karpisek; David Stejskal; Zhi-Guang Zhou; Feng Liu; Rachel L C Wong; Wing-Sun Chow; Annette W K Tso; Karen S L Lam; Aimin Xu
Journal:  Diabetes       Date:  2008-02-05       Impact factor: 9.461

8.  Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.

Authors:  Bee K Tan; Manfred Hallschmid; Raghu Adya; Werner Kern; Hendrik Lehnert; Harpal S Randeva
Journal:  Diabetes       Date:  2011-09-16       Impact factor: 9.461

Review 9.  Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies.

Authors:  Lee Hooper; Asmaa Abdelhamid; Helen J Moore; Wayne Douthwaite; C Murray Skeaff; Carolyn D Summerbell
Journal:  BMJ       Date:  2012-12-06

Review 10.  Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis.

Authors:  Deirdre K Tobias; Mu Chen; JoAnn E Manson; David S Ludwig; Walter Willett; Frank B Hu
Journal:  Lancet Diabetes Endocrinol       Date:  2015-10-30       Impact factor: 32.069

View more
  21 in total

Review 1.  Impact of Genes and Environment on Obesity and Cardiovascular Disease.

Authors:  Yoriko Heianza; Lu Qi
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

2.  Starch Digestion-Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: The POUNDS Lost Trial.

Authors:  Yoriko Heianza; Dianjianyi Sun; Tiange Wang; Tao Huang; George A Bray; Frank M Sacks; Lu Qi
Journal:  Diabetes       Date:  2017-06-28       Impact factor: 9.461

3.  Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial.

Authors:  Christopher D Gardner; John F Trepanowski; Liana C Del Gobbo; Michelle E Hauser; Joseph Rigdon; John P A Ioannidis; Manisha Desai; Abby C King
Journal:  JAMA       Date:  2018-02-20       Impact factor: 56.272

4.  Effects of a Paleolithic Diet on Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Ehsan Ghaedi; Mohammad Mohammadi; Hamed Mohammadi; Nahid Ramezani-Jolfaie; Janmohamad Malekzadeh; Mahdieh Hosseinzadeh; Amin Salehi-Abargouei
Journal:  Adv Nutr       Date:  2019-07-01       Impact factor: 8.701

Review 5.  Low-carbohydrate diets and cardiometabolic health: the importance of carbohydrate quality over quantity.

Authors:  John L Sievenpiper
Journal:  Nutr Rev       Date:  2020-08-01       Impact factor: 7.110

6.  Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study.

Authors:  Yang Hu; Gang Liu; Jennifer Rood; Liming Liang; George A Bray; Lilian de Jonge; Brent Coull; Jeremy D Furtado; Lu Qi; Philippe Grandjean; Qi Sun
Journal:  Environ Res       Date:  2019-09-27       Impact factor: 6.498

7.  Genetic susceptibility, lifestyle intervention and glycemic changes among women with prior gestational diabetes.

Authors:  Zhaoxia Liang; Leishen Wang; Huikun Liu; Yuhang Chen; Tao Zhou; Yoriko Heianza; Junhong Leng; Weiqin Li; Xilin Yang; Yun Shen; Ru Gao; Gang Hu; Lu Qi
Journal:  Clin Nutr       Date:  2019-09-10       Impact factor: 7.324

Review 8.  The aetiology and molecular landscape of insulin resistance.

Authors:  David E James; Jacqueline Stöckli; Morris J Birnbaum
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-20       Impact factor: 94.444

Review 9.  Homeostatic sensing of dietary protein restriction: A case for FGF21.

Authors:  Cristal M Hill; Hans-Rudolf Berthoud; Heike Münzberg; Christopher D Morrison
Journal:  Front Neuroendocrinol       Date:  2018-06-08       Impact factor: 8.606

Review 10.  Obesity genetics and cardiometabolic health: Potential for risk prediction.

Authors:  Dharambir K Sanghera; Cynthia Bejar; Sonali Sharma; Rajeev Gupta; Piers R Blackett
Journal:  Diabetes Obes Metab       Date:  2019-03-20       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.